PDCD1 and neoplasm: Furthermore, the treatment strategy of cryoablation combined with anti-PD1 and anti-Ly6G further delays tumor progression and stabilizes tumor volume, suggesting that NETs may serve as a potential target for enhancing immunotherapy efficacy post-cryoablation.